A Community Screening Program for Helicobacter pylori Saves Money: 10-Year Follow-up of a Randomized Controlled Trial

Gastroenterology - Tập 129 - Trang 1910-1917 - 2005
Alexander C. Ford1, David Forman2, Alastair G. Bailey1, Anthony T.R. Axon1, Paul Moayyedi3
1Centre for Digestive Diseases, Leeds General Infirmary, Leeds, United Kingdom
2Centre for Epidemiology and Biostatistics, Leeds University Medical School, Leeds, United Kingdom
3Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, Ontario, Canada

Tài liệu tham khảo

Ferlay, 2004 2001, Gastric cancer and Helicobacter pylori, Gut, 49, 347, 10.1136/gut.49.3.347 Moayyedi, 1997, Helicobacter pylori and gastric cancer, Gastrointest Endosc Clin N Am, 7, 47, 10.1016/S1052-5157(18)30322-2 Wong, 2004, Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China, JAMA, 291, 187, 10.1001/jama.291.2.187 Parsonnet, 2004, Helicobacter pylori infection and gastric cancer—for want of more outcomes, JAMA, 291, 244, 10.1001/jama.291.2.244 Megraud, 1997, How should Helicobacter pylori infection be diagnosed?, Gastroenterology, 113, S93, 10.1016/S0016-5085(97)80020-0 Ford, 2003, How can current strategies for Helicobacter pylori eradication therapy be improved?, Can J Gastroenterol, 17, b36, 10.1155/2003/714124 Kuipers, 1993, Seroconversion for Helicobacter pylori, Lancet, 342, 10.1016/0140-6736(93)91473-Y Parsonnet, 1996, Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer, Lancet, 348, 150, 10.1016/S0140-6736(96)01501-2 Sonnenberg, 1998, Medical decision models of Helicobacter pylori therapy to prevent gastric cancer, Aliment Pharmacol Ther, 12, S111, 10.1111/j.1365-2036.1998.00001.x Ford, 2004, Eradication therapy in Helicobacter pylori positive peptic ulcer disease, Am J Gastroenterol, 99, 1833, 10.1111/j.1572-0241.2004.40014.x Moayyedi, 2003, An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in non-ulcer dyspepsia, Am J Gastroenterol, 98, 2621, 10.1111/j.1572-0241.2003.08724.x Moayyedi, 2000, Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community, Lancet, 355, 1665, 10.1016/S0140-6736(00)02236-4 Mason, 2002, The cost-effectiveness of population Helicobacter pylori screening and treatment, Aliment Pharmacol Ther, 16, 559, 10.1046/j.1365-2036.2002.01204.x Moayyedi, 1998, The Leeds Dyspepsia Questionnaire, Aliment Pharmacol Ther, 12, 1257, 10.1046/j.1365-2036.1998.00404.x NHS reference costs 2002. Department of Health. Available at: http://www.dh.gov.uk/Home/fs/en. Accessed January 31, 2004. The British National Formulary number 46, September 2003. Available at: http://www.bnf.org/bnf. Accessed April 12, 2005. Fraser, 2003, Validation of the short-form Leeds dyspepsia questionnaire (SF-LDQ) in a community setting, Gastroenterology, 124, A224, 10.1016/S0016-5085(03)81126-5 Moayyedi, 2002, Clinical and economic consequences of dyspepsia in the community, Gut, 50, 10